International Journal of STD & AIDS 2006; 17: 7–13
retarded ejaculation: BASHH Special Interest
Daniel Richardson BSc MRCP and David Goldmeier MD FRCP, on behalf
of the BASHH Special Interest Group for Sexual Dysfunction
Jane Wadsworth Clinic, Jefferiss Wing, St Mary’s Hospital, London W2 1NY, UK
Summary: We present the British Association of Sexual Health and HIV (BASHH)special interest group in sexual dysfunction recommendations for the managementof retarded ejaculation. The recommendations outline the physiology, prevalence,definitions, aetiological factors and patient assessment for this sexual problem. Wesuggest treatment strategies, recommendations for management and an auditableoutcome.
Keywords: retarded ejaculation, recommendations, management, BASHH
448 they assessed and treated in an 11-year period.3Helen Kaplan stated that her sample size was too
Sexual climax in men usually has two contempora-
insignificant to report.4 Studies from the late 1970s
neous components – orgasm, an intensely pleasur-
provided estimates of prevalence ranging from
able subjective feeling, together with semen being
4% to 10%.5,6 Population samples from the 1990s
ejaculated from the penis. It has been postulated
quoted lower rates ranging from 0% to 3%.7–9 There
that the various constituents of semen entering
are some later, albeit bias studies, which found
the posterior urethra creates a ‘pressure chamber’
rates of 20–39% in homosexual men, and HIV-
within the posterior urethra.1 This triggers the
infected men.10–12 A 2003 prospective cross-sec-
closure of the neck of the bladder and subsequent
tional sample of men attending general practi-
rhythmical coordinated reflex contractions of the
tioners in London reported a rate of 11%.13
striated pelvic muscles, and antegrade ejaculation
In ‘sexual dysfunction in the US: prevalence and
of semen. The physiological process of ejaculation
predictors’, Laumann and colleagues analysed data
is under autonomic control via the hypogastric
collected in the national health and social life
(sympathetic) and pudendal (parasympathetic)
survey, and generated prevalence and calculated
nerves.1 The exact site of the generation of
associated risk factors for sexual dysfunctions.14
orgasmic pleasure within the brain is unknown.
This epidemiological analysis looked at represen-
In these recommendations we concentrate on
tative sample of American men aged 18 and 59
men who have difficulty with ejaculation, which
years. They found that 7.8% (97/1246) of men
may or may not be associated with subjective
reported retarded ejaculation occurring for at least
Retarded ejaculation (also known as the male
A more detailed population-based study in the
orgasmic disorder, inhibited ejaculation, impaired
UK of 5000 16–44-year-old men found that 5.3%
ejaculation, delayed ejaculation, ejaculatory incom-
said that they had experienced an inability to reach
petence, anejaculation, impaired orgasm, inhibited
orgasm for at least one month in the past year, but
male orgasm, ejaculatory overcontrol) is defined by
only 2.9% had experienced the problem for at least
the American Psychiatric Association (APA) as:
six months in the past year, suggesting that the
‘.the persistent or recurrent difficulty, delay in, or
problem affects many men some of the time.15
absence of attaining orgasm following sufficientsexual stimulation, which causes personal distress.’2
AetiologyThe conventional causes are shown in Table 1. A
meta-analysis, which included 560 men, stratified
Most texts state that retarded ejaculation is rare.
causation as: spinal cord injury (68.9%), retro-
Masters and Johnson reported only 17 cases out of
peritoneal lymph node dissection (20.7%), diabetesmellitus (2.1%), trauma/retroperitoneal surgery
(0.9%), multiple sclerosis (0.4%), bladder neck
surgery (0.2%) unknown or idiopathic (7.1%).16
Table 2 Age as a predictor for retarded ejaculation14
Transurethral resection of prostateBladder neck inscision
There is a progressive loss of the fast-conduction
peripheral sensory axons, which begins to be
apparent in the third decade of life, which may
result in a degree of age-related degenerative
changes, resulting in difficulty in achieving the
Other factors which are suggested to have an
effect upon the ageing effect of sexual function are:peripheral vascular disease, diabetic neuropathy,
psychiatric illness and lifestyle issues (smoking,
alcohol, physical inactivity, boredom and lone-
liness).23 Decreased sensitivity of the penis with
age has been reported and may contribute to theincrease in ejaculation times seen with age.25
Despite this, Laumann, in his cross-sectional
population-based epidemiological survey, couldnot identify age as a predictor of retarded ejacula-tion (Table 2); however, this study excluded
men who were not sexually active or over 60 yearsold.14
It is biologically plausible that men with retardedejaculation have slower bulbo-cavernous reflexes,lesser penile sensitivity, reduced spinal stimulation
and a higher penile sensory threshold than func-tional men. Indeed, Brindley and Gillan found the
Mullerian and Wolfferian duct malformation are
bulbo-cavernosus or glandipudendal reflex to be
embryonic abnormalities, which would plausibly
absent in two out of nine men with complete
lead to a physiological inability for a man to
ejaculate.24 Persistence of a small remnant of the
Shull and Spenkle suggest that inadequate sexual
Mullerian duct may lead to a cyst forming between
stimulation may be the problem.18 There is evi-
the ejaculatory ducts.26 This can cause obstructed
dence that men have ‘autosexual orientation’: they
and diminished ejaculate, which may impede the
prefer manual stimulation by their own hand
trigger for ejaculation by the absence of ‘filling of
rather than partnered sex (of any kind) because
the posterior urethra’ and reduced ‘prostatic
they know how to optimally manipulate them-
chamber pressure’.1 Congenital anomalies of the
selves.19,20 Furthermore, men who experience con-
Wolffian duct may be either sporadic with a
stant (as opposed to varied) sexual stimulation via
localized defect in the proximal part of the vas
a mechanism of habituation are probably less likely
deferens, or there may be a generalized maldeve-
to achieve ejaculation and orgasm over time.21
lopment due to a systemic genetic abnormality.27
There are some data describing men who develop
The latter is usually associated with the cystic
an ‘idiosyncratic style’ of genital stimulation dur-
fibrosis gene.28 Ejaculatory duct obstruction or
ing masturbation, thus disabling their ability to
ejaculatory failure due to pelvic nerve damage
ejaculate during penetrative sexual intercourse.19,22
may follow correction of an imperforate anus.
Pelvic surgery may affect a man’s ejaculatory
There is evidence that as men age, sexual organs
function. Radical prostatectomy, whereby the
atrophy, diminished testosterone levels, delay in
seminal vesicles are removed, results in loss of
attaining erections, reduced erection quality, longer
ejaculation (along with erectile function and
in achieving and maintaining a full erection and
orgasm).26 Nerve-sparing procedures were sub-
decline in intensity of orgasm all can occur.23
sequently developed to avoid postoperative loss
Recommendations for the management of retarded ejaculation
of sexual function.29 Trans-urethral resection of
understood the effect of alcohol on sexual perfor-
the prostate (a common surgical procedure for
mance: ‘Alcohol provokes the desire, but takes
benign prostatic hypertrophy) and bladder neck
away the performance.’ (Shakespeare, Macbeth;
surgery have both been shown to cause retarded
Act II, Scene 3). Isotretinon (accutane), episilon
aminocaproic acid, acetazolamide and naproxenhave all been reported to cause retarded ejacula-tion.38–40 Monoamine oxidase inhibitors (antide-
pressants) and guanethidine (antihypertensive)
The ability to ejaculate is impaired by spinal cord
have been shown in small series to cause retarded
injury. Unlike erectile function, the ability to
ejaculate increases with descending levels of spinal
Selective serotonin re-uptake inhibitors (SSRIs),
injury.30 The ability to ejaculate is severely im-
tricyclic antidepressants, alpha blockers have all
paired by spinal cord injuries and is dependent
upon the level and completeness of the injury.30
placebo-controlled trials to retard ejaculation in
Less than 5% of men with complete upper motor
men with premature ejaculation compared with
neurone lesions retain the ability to ejaculate.
Sexual problems in multiple sclerosis include
erectile dysfunction, ejaculatory disorders and
Shull and Spenkle commented that: ‘If the literatureis searched long enough, almost any and every
psychological problem can be associated with male
A case control study of 95 men with type 1 diabetes
shows a statistical relationship between complica-
tions of diabetes and ‘orgasmic dysfunction’.32,33
ambivalent about his commitment to a sexualrelationship may ‘hold back’ as a way of ‘assumingpower’ in a troubled relationship.60 Kaplan shares
this view, proposing that some men with thisproblem are overcontrolled individuals and resist
Many pharmacological agents have been shown to
‘letting themselves go’ because of hostile feelings
cause retarded ejaculation (Table 3). In fact, all of
the drugs approved for the treatment of depression
Blandy takes a more practical (situational) view.
or obsessive–compulsive disorder, with the excep-
He considers, ‘ythe creaking bed, the thin parti-
tion of nefazodone, and bupropion and possibly
tion or the toddlers wandering about in search of
escitralopram have been reported to be associated
a ‘glass’ of watery’ are powerful inhibitors of
with ejaculatory or orgasmic difficulty.34,35 Antic-
orgasm and ejaculation. He also considers pain
holinergic, antiadrenergic, antihypertensive and
as an inhibitory experience: a prepuce, which
psychoactive drugs are also common causes of
becomes painfully stretched over an erect penis,
There are no published data on the effects of
thiazide diuretics on ejaculation: however, thesedrugs reduce serum zinc, which may interfere with
testosterone metabolism.37 There is a surprisinglack of quality scientific evidence for alcohol’s
effect upon ejaculation: Shakespeare, however,
This should include an assessment of whether theproblem is ejaculatory, orgasmic or both. Asso-ciated personal, social or cultural issues as well as a
Table 3 Drugs known to be associated with retarded ejaculation
brief psychiatric and medical history should be
attained. Careful consideration of prescribed and
non-prescribed drugs, including alcohol and the
presence of desire and erectile difficulties, should
Atypical antidepressants (Trazodone)Beta blockersBaclofen
BenzodiazepinesMono-amine oxidase inhibitors
An assessment of the penis and other sexual
characteristics is necessary. A careful examination
of the nervous system should be carried out to
exclude peripheral neuropathy, autonomic dys-
function (by means of lying and standing blood
pressure) and spinal cord pathology.
cyproheptadine and yohimbine, which successfullyreversed their ejaculatory problem64 (Level of
A serum glucose and investigation of nervous
disease should be undertaken as appropriate.
Bupropion is a serotonin/norepinephrine/dopa-
We consider that all new patients merit at least a
mine re-uptake inhibitor and has been investigated
30 minute–1 hour consultation time for their first
in men with SSRI-induced sexual dysfunction with
appointment: however, we are aware that due to
differing results.65–67 Despite this, bupropion has
local clinic time constraints and waiting times, this
been reported to cause a reversal of SSRI-induced
retarded ejaculation66 (Level of evidence III).
Buspirone, a 5HT1A agonist, has been reported
in a prospective study of depressed men and
women with generalized sexual dysfunction toreverse the sexual dysfunction side-effects of
SSRIs including retarded ejaculation68 (level of
Clearly, treatment depends upon a correct diag-
nosis, which requires a detailed medical and sexual
Cyproheptadine is a serotonin and histamine
history, physical examination and appropriate
agonist which has successfully been reported to
physiological investigations and imaging, to iden-
reverse the retarded ejaculation caused by imipra-
tify organic causes such as drugs, pelvic surgery,
mine, nortryptiline, fluoxetine, fluvoxamine andclomipramine69–73 (Level of evidence III). Of note,
cyproheptadine has a tendency to cause drowsi-ness, which may affect sexual functioning.74 Cy-
proheptadine has also been reported to reversecitralopram-induced retarded ejaculation75 (level of
Retarded ejaculation as a consequence of drug
evidence III). Yohimbine is an alpha-2 adrenergic
therapy for other conditions (e.g. depression) needs
antagonist. Yohimbine has been reported to reverse
to be carefully considered and discussed with
the retarded ejaculation caused by clomipramine,
patients on an individual level. Cessation (partial
fluvoxamine, fluoxetine, sertraline and paroxe-
or permanent) of potentially causative pharmaco-
tine74,76,77 (level of evidence III).
logical agents requires discussion with their psy-chiatrist or general practitioner.
A variety of drugs are reported to have efficacy
in men with retarded ejaculation taking antide-pressants. The drugs reported have been suggested
Sex and psychotherapy texts recommend medita-
to facilitate ejaculation by either a central dopami-
tive relaxation combined with psychotherapy.78
nergic or antiserotonergic mechanism. Most reports
Other authors recommend the addition of viewing
concentrate on the management of SSRI-induced
erotic films, sex play, erotic fantasies, sexually
retarded ejaculation (Table 4). Discussion with
stimulating literature or magazines, and masturba-
the patient’s psychiatrist or general practitioner
tory exercises.60,79 Munjack and Kanno report a
success rate for sex therapy between 42% and 82%
treatment of depression or anxiety disorders,
in a meta-analysis36 (level of evidence IV).
which may include drug holidays, may be con-
Bancroft assumes in his therapeutic methods that
inadequate stimulation is the ‘block’ to ejaculation,
Amantadine induces the release of dopamine
as he recommends the use of, ‘vigorous stimulation
centrally. There have been two reports of using
using a lubricating jelly or cream to overcome
amantadine to treat fluoxetine-induced retarded
the block’.80 This technique follows on that once
ejaculation62,63 (level of evidence III). A small
a man can ejaculate extra-vaginally, his penis is
retrospective cohort study of men with SSRIs-
then introduced closer and closer to the vaginal
associated sexual dysfunction used amantadine,
opening, introducing short periods of vaginal entryinto the procedure (level of evidence IV).
Hawton discusses that during masturbatory
exercises with the partner, the man must be trained
Table 4 Adjunctive pharmacotherapy for SSRI-induced retardedejaculation24
to concentrate on genital stimulation.79 He alsorecommends the male-superior position as he
postulates that this often facilitates ejaculation. Hawton, Bancroft and Winzce recommend the use
of vibrators to increase sexual arousal60,79,80 (level
Practical aspects of therapy are outlined clearly
by Jannini and colleagues.81 They advise that any
fears or anxieties such as fear of pregnancy and
SSRI=selective serotonin re-uptake inhibitors
sexually transmitted diseases should be discussed
Recommendations for the management of retarded ejaculation
at the outset. Hypnosis has been described as a
useful adjunct to therapy82 (level of evidence IV).
Evidence obtained from meta-analysis of randomized
Delmonte described a meditative relaxation meth-
od together with brief supportive psychotherapy
Evidence obtained from at least one randomized controlled
for both partners in a report of two couples.78 Sex
play as a treatment for retarded ejaculation has
Evidence obtained from at least one well-designed
been described anecdotally in a small cohort83,84
Evidence obtained from at least one well-designed
Evidence from well designed non-experimental studies such
as comparative studies, correlation studies and case
Evidence obtained from expert committee reports or
Retarded ejaculation is an uncommon problem,
opinions and/or clinical experiences of respected
which may present to genitourinary medicine
settings. The definition of this condition does notappear to have reached consensus among alltherapists and researchers. There are few casereports and case-controlled studies describing
possible aetiological factors and associations; how-
1 Levin RJ. The mechanism of human ejaculation – a critical
ever, well constructed, hypothesis testing trials for
analysis. J Sex Relat Ther 2005;20:123–31
these factors have not been done. It seems clear that
2 American Psychiatric Association. Diagnostic and Statistics
many psychoactive drugs may cause retarded
Manual of Mental Disorders. 4th edn. Washington, DC:
ejaculation. Careful consideration of drug-induced
sexual problems needs to be considered when
3 Masters WH, Johnson VE. Human Sexual Inadequacy. Boston:
prescribing such agents and awareness of possible
antidotes. Although the literature is lacking in
4 Kaplan HS. The New Sex Therapy. New York: Brunner Mazel,
quality scientific evidence for the management of
5 Frank E, Anderson C, Rubenstein D. Profiles of couples
this condition, a wealth of anecdotal and expert
seeking sex therapy and marital therapy. Am J Psychiat
opinion is available, particularly from psycho-
logists and psychosexual therapists. Surely, there-
6 Nettelbladt P, Uddenberg N. Sexual dysfunction and sexual
fore, an eclectic approach is needed for patients
satisfaction in 58 married Swedish men. J Psychosom Med
presenting with this condition, which includes
7 Fugl-Meyer AR, Sjogren Fugl-Meyer K. Sexual disabilities,
screening for possible identifiable organic and
problems and satisfaction in 18–74 year olds Swedes. Scand J
psychosocial factors, clear discussion with patients
and their partners, and subsequent tailoring of
8 Lindal E, Stephansson JG. The lifetime prevalence of
psychosexual dysfunction among 55–57 year olds in Iceland. Social Psychiat Psychiat Epidemiol 1993;28:91–5
9 Solstad K, Hertoft P. Frequency of sexual problems and
sexual dysfunction in middle aged Danish men. Arch Sexual
10 Catalan J, Klimes I, Bond A, Day A, Garrod A, Rizza C.
The psychosocial impact of HIV infection in men with
The diagnosis of retarded ejaculation is from
haemophilia: controlled investigation and factors associated
clinical history based on the DSM IV.
In men with concomitant erectile dysfunction,
the erectile dysfunction should be treated first
11 Catalan J, Klimes I, Day A, Garrod A, Bond A, Gallwey J.
The risks and benefits of all treatment options
The psychosocial impact of HIV infection in gay men. Acontrolled investigation and factors associated with psy-
should be discussed with patients prior to any
intervention. Patient and partner satisfaction is
12 Rosser BR, Metz ME, Bockting WO, Buroker T. Sexual
difficulties, concerns and satisfaction in homosexual men:
Management of patients should be decided on a
an empirical study with implications for HIV prevention.
case-by-case basis: an eclectic approach should
13 Nazareth I, Boynton P, King M. Problems with sexual
function in people attending London general practitioners:
Patients should be aware that pharmacological
cross sectional study. BMJ 2003;327:423–6
adjuvants to SSRI-induced retarded ejaculation
14 Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the
are not licensed uses of these products.
United States: prevalence and predictors. JAMA 1999;281:537–544
15 Mercer CH, Fenton KA, Johnson AM, et al. Sexual function
problems and health seeking behaviour in Britain: prob-
ability sample survey. BMJ 2003;327:426–7
16 Kamischke A, Nieschlag E. Update on medical treatment of
Auditable outcomes: All patients with retarded
ejaculatory disorders. Int J Androl 2002;25:333–44
ejaculation must have a full history (including
17 Bindley GS, Gillan P. Men and women who do not have
sexual history) and clinical examination.
orgasms. Br J Psychiatry 1982;140:351–6
18 Shull GR, Sprenkle DH. Retarded Ejaculation: reconceptua-
44 Choi HK, Xin ZC, Choi YD, Lee WH, Mah SY, Kim DK.
lisation and implications for treatment. J Sex Marital Ther
Safety and efficacy study with various doses of SS-cream in
patients with premature ejaculation in a double-blind,
19 Lipsith J, McCann D, Goldmeier D. Male psychogenic
randomized, placebo controlled clinical study.
dysfunction: the role of masturbation. J Sex Relat Ther
45 Haensel SM, Rowland DL, Kallan K, Slob KA. Clomipra-
20 Apfelbaum retarded ejaculation: a much misunderstood
mine and sexual function in men with premature ejacula-
syndrome. In: Lieblum SR, Rosen RC, eds. Principals and
Practice of Sex Therapy. 3rd edn. New York: Guilford,
46 Hamid-Abdel IA, El Naggar EA, El Gilany AH. Assessment
of as needed use of pharmacotherapy and the pause
21 O’Donohue WT, Geer JH. The habituation of sexual arousal.
squeeze technique in premature ejaculation.
22 Sank LI. Traumatic masturbatory syndrome. J Sex Marital
47 Kara H, Aydin S, Agargun MY, Odabas O, Yilmaz Y. The
efficacy of fluoxetine in the treatment of premature
23 Gregoire A. ABC of sexual health: male sexual problems –
ejaculation: a double blind placebo controlled study.
24 McMahon CG, Abdo C, Incrocci L, et al. Disorders of
48 Kim SC, Keun K. Efficacy and safety of Fluoxetine, Sertra-
orgasm and ejaculation in men. J Sexual Med 2004;1:58–64
line and Clomipramine in patients with premature ejacula-
25 Edwards AE, Husted JR. Penile sensitivity, age and sexual
49 Ludovico GM, Corvasce A, Pagliarulo G, Cirillo-Marucco E,
26 Hendry WF. Disorders of ejaculation: congenital, acquired
Marano A, Pagliarulo E. Paroxetine in the treatment of
and functional. Br J Urol 1998;82:331–41
27 Schlegel PN, Shin D, Goldstein M. Urological anomalies in
50 McMahon CG. Treatment of premature ejaculation with
men with congenital absence of the vas deferens. J Urol
Sertraline: a single blind controlled crossover study.
28 Mickle J, Mulunsky A, Amos JA, Oates RD. Congenital
51 McMahon CG, Touma K. Treatment of premature ejacula-
absence of the vas deferens: a heterogeneous disorder with
tion with paroxetine hydrochloride as needed: 2 single-
two distinct subpopulations based upon aetiology and
mutational status if the cystic fibrosis. Hum Reprod
52 Mendels J, Camera A, Sikes C. Sertraline treatment for
29 Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual
function after radical prostatectomy: influence of preserva-
53 Salonia A, Tommaso M, Colombo R, et al. A prospective
tion of neurovascular bundles. J Urol 1991;15:998–1002
study comparing paroxetine versus paroxetine plus
30 Bores E, Comarr AE. Neurological disturbances of sexual
sildenafil in patients with premature ejaculation.
function with special reference to 529 patients with spinal
54 Strassberg DS, Gouveia Brazao CA, Rowland DL, Tan P,
31 DasGupta R, Fowler CJ. Sexual and urological dysfunction
Slob K. Clomipramine in the treatment of rapid (premature)
in multiple sclerosis better understanding and improved
therapies. Curr Opin Neurol 2002;15:271–8
55 Waldinger MD, Hengeveld MW, Zwinderman AH. Parox-
32 Thomas A, Lopicollo J. Sexual function in persons with
etine treatment of premature ejaculation: a double blinded,
diabetes: issues in research, treatment and education. ClinPsychol Rev 1994;14:1–86
33 Enzlin P, Mathieu C, Van Den Bruel A, Vanderschueren D,
Demyttenaere K. Prevalence and predictors of sexual
56 Waldinger MD, Hengeveld MW, Zwinderman AH. Ejacula-
dysfunction in patients with Type I diabetes. Diab Care
tion retarding properties of paroxetine: a double blind
34 Seagraves RT. Antidepressant induced orgasm disorder.
57 Waldinger MD, Hengeveld WM, Zwinderman AH, Oliver
B. Effects of SSRI antidepressants on ejaculation: a double
35 Ashton A, Mahmood A, Iqbal F. Improvements in SSRI/
blind randomised placebo-controlled study.
SNRI-induced sexual dysfunction by switching to escitalo-
pram. J Sex Marital Ther 2005;31:257–62
58 Waldinger MD, Zwindweman AH, Oliver B. SSRIs and
36 Munjack DJ, Kanno PH. Retarded ejaculation: a review. Arch
ejaculation: a double blind, randomised, fixed dose study
37 Morley JE, Korenman SG, Mooradian AD, Kaiser FE. UCLA
geriatric grand rounds: sexual dysfunction in the elderly
59 Yilmaz U, Tatlisen A, Turan H, Arman F, Ekmekcioglu O.
The effects of Fluoxetine on several neuro-physiological
38 Evans BE, Adedort LM. Inhibition of ejaculation due
variables in patients with premature ejaculation.
to epsilon aminocaproic acid. N Engl J Med 1978;298:
60 Wincze JP, Carey MP. Sexual Dysfunction. A Guide for
39 Epstein DL, Grant WM. Carbonic anhydrase inhibitor side
Assessment and Treatment. 2nd edn. London: The Guilford
40 Miller LG. Indomethacin associated sexual dysfunction. J
61 Blandy J. Sexual Problems seen in Urology. Psychosexual
41 Drugs that cause sexual dysfunction – an update. Med Lett
62 Balogh S, Hendricks SE, Kang J. Treatment of fluoxetine-
induced anorgasmia with Amantadine. J Clin Psychiat
42 Chia SJ. Management of premature ejaculation – a compar-
ison of treatment outcome in patients with and without
63 Shrivastava RK, Shrivastava S, Overweg N, Schmitt M.
Amantadine in the treatment of sexual dysfunction asso-
43 Choi HK, Jung GW, Moon KH, et al. Clinical study of SS
cream in patients with lifelong premature ejaculation.
64 Ashton AK, Hamer R, Rosen R. SSRI induced sexual
dysfunction and its treatment: a large-scale retrospective
Recommendations for the management of retarded ejaculation
study of 596 psychiatric outpatients. J Sex Marital Ther
74 Seagraves RT. Treatment of drug induced anorgasmia. Br J
65 Gitlin MJ, Suri R, Altshuler L, Zuckerbrow-Miller J,
75 Lauerma H. Successful treatment of citralopram induced
Fairbanks L. Bupropion-sustained release as a treatment
for SSRI-induced sexual side effects. J Sex Marital Ther
76 Price J, Grunhaus LJ. Treatment of clomipramine induced
66 Labbate LA, Pollack MH. Treatment of fluoxetine induced
anorgasmia with yohimbine: a case report.
sexual dysfunction with bupropion: a case study.
77 Hollander E, McCarley A. Yohimbine treatment of sexual
67 Masand PS, Ashton AK, Gupta S, Bradford F. Sustained
side effects induced by SSRIs. J Clin Psychiatr 1992;53:207–9
release bupropion for SSRI induced sexual dysfunction: a
78 Delmonte MM. Case reports on the use of meditative
randomised double blind placebo controlled, parallel-group
relaxation as an intervention strategy with retarded ejacula-
tion. Biofeedback Self Regul 1984;9:209–14
68 Landen M, Eriksson E, Agren H, Fahlen T. Effect of
79 Hawton K. Sex Therapy – A Practical Guide. Oxford: Oxford
buspirone on sexual dysfunction in depressed patients
treated with selective serotonin reuptake inhibitors. J Clin
80 Bancroft J. Human Sexuality and its Problems. 2nd edn.
69 Steele TE, Howell F. Cyproheptadine for imipramine
81 Jannini EA, Simonelli C, Lenzi A. Sexological approach to
induced anorgasmia. J Clin Psychopharmacol 1986;6:326–7
ejaculatory dysfunction. Int J Androl 2002;25:317–23
70 Sovner R. Treatment of tricyclic induced orgasmic in-
82 Zilbergeld B. Group treatment of sexual dysfunction in men
hibition with cyproheptadine. J Clin Psychopharmacol 1984;
without partners. J Sex Marital Ther 1975;1:204–14
83 Shaw J. Play therapy with the sexual workhorse: successful
71 McCormick S, Olin J, Brotman AW. Reversal of fluoxetine
treatment with twelve cases of inhibited ejaculation. J Sex
induced anorgasmia by cyproheptadine in two patients.
84 Dow Michael G. Retarded ejaculation as a function of
72 Arnott S, Nutt D. Successful treatment of fluvoxamine
non-aversive conditioning and discrimination: a hypothesis.
induced anorgasmia by cyproheptadine. Br J Psychiat
73 Riley AJ, Riley EJ. Cyproheptadine and antidepressant
induced anorgasmia. Br J Psychiat 1986;148:217–18
9433 The Killers Within 8/6/02 11:18 AM Page 291 acknowledgments To embrace a field as broad and complex as drug-resistant bacteria,with all the microbiology it entails, then try to make it simple, clear,and compelling, we needed a lot of wise counsel. J. Glenn Morris Jr. of the University of Maryland’s Baltimore Veterans Affairs MedicalCenter was one such guru; we are grateful not only for h
L E I N E N & D E R I C H S A N W A L T S O Z I E TÄT MEDIZINRECHT - März/April 2008 - 50668 KÖLN Clever Straße 16 Telefon 0221 - 77 20 9-0 Telefax 0221 - 72 48 89 Email 10718 BERLIN Rosenstraße 2 Telefon 030 - 24 102 153 Telefax 030 - 24 102 22 Email www.leinen-derichs.de I. KRANKENHAUS & KLINIK S. 3 1. Vergütung: Zulässigkeit